| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-21 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-15 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-14 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-09 |